TriSalus Life Sciences, Inc. (TLSI)
NASDAQHealth CareMedical - DevicesSnapshot 2026-11-04
$3.89+11.78%
Close 2026-11-04 · 1-day change
NASDAQHealth CareMedical - DevicesSnapshot 2026-11-04
QuarterlyIQ Insights · TLSI
What must go right, what could break, what the price assumes, and what evidence comes next.
The current health of the standing investment case.
Recent financial performance sits well below its industry cohort — worth keeping an eye on, though it has not freshly broken.
One-year growth currently built into the price, compared with our model's estimate.
| Measure | Marker shape | Value |
|---|---|---|
| Growth built into the price | circle | -50.2% |
| Our one-year growth estimate | diamond |
For each item: what to watch, what would become a concern, and what would make it less concerning.
A reporting-risk estimate, not a forecast of the stock-price response.
Historical relationships that met the evidence threshold. They do not prove cause or forecast a move.
No outside relationship met the current evidence threshold.
Based on historical daily prices through 2026-11-04.
Past price behavior in dollars on a $10,000 position. This does not measure permanent business risk.
How much price usually moves either way.
Use the underlying financial and sector pages to investigate the cause.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
| 54.4% |
Growth built into the price is above our model estimate.
The price assumes 104.7 percentage points less one-year growth.
The one-year revenue growth assumption on Valuation.
Model as of 2026-11-04 · Compared with 29 industry peers
TLSI — earnings miss
Dated 2026-08-06
Results of Operations and Financial Conditions. On August 6, 2026, TriSalus Life Sciences, Inc. (the “Company”) issued a press release announcing its financial results for the second quarter ended June 30, 2026. A copy of the press release is attached hereto as Exhibit 99.1 to this Current Report on Form 8-K and incorporated herein by reference. This information, including Exhibit 99.1, will not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (t…
Why it matters: Management kept this range after Q2 revenue rose to $11.4 million. Reaching it would show that sales growth is catching up with the expanded sales team.
Supportive ifFull-year 2026 revenue is at least $54 million and no more than $57 million.
Worry ifFull-year 2026 revenue falls below $54 million, or management cuts the range.
Why it matters: CMS created a G-code for covered procedures in office-based labs, but the payment rate was not final. The rate will show how much support this site of care gets.
Watch forCMS sets a payment rate. TriSalus says it supports use of covered procedures in office-based labs.
Also watch forCMS sets a rate that TriSalus says limits use in office-based labs. Or CMS does not set a rate in the coming months.
Why it matters: The device extends PEDD to small distal vessels. Sales would show whether the new clearance adds to the business.
Supportive ifA company update names TriNav Advance sales or reports its first revenue.
Worry ifThe next company update reports no launch or sales progress for TriNav Advance.
Why it matters: Q2 operating losses rose as sales and marketing costs grew. Further losses would show that expansion costs still outpace revenue gains.
Worry ifQ3 operating loss is greater than $9.8 million.
Less concerning ifQ3 operating loss is $9.8 million or less, while revenue rises from Q2's $11.4 million.
A larger daily loss that occurred about once in every 20 trading days.
Deepest peak-to-trough drop in the last year.
| Measure | Value | Meaning |
|---|---|---|
| Typical day | ±$215 on $10,000 · ±2.2% | How much price usually moves either way. |
| Bad day | $666 loss on $10,000 · 6.7% | A larger daily loss that occurred about once in every 20 trading days. |
| Largest peak-to-trough drop in the past year | $6,640 loss on $10,000 · 66.4% | Deepest peak-to-trough drop in the last year. |
Past year. 1.00 means similar movement; 1.20 means about 20% more.
Past year. 1.00 means similar movement to the sector. This is secondary context.
Latest 30 trading days, shown as an annual percentage.
Latest 252 trading days, shown as an annual percentage.
20-trading-day average in US dollars.
Trading days used by the source risk snapshot.
Past results, not a forecast. Not investment advice.